HealthTech startup Medeloop has raised USD 8 million in an oversubscribed seed funding round led by General Catalyst, with participation from Maven Ventures, Ovo Fund, NV Investment, and other investors. This brings the total funds raised by the company to USD 10 million.
The funds will be used to launch an end-to-end solution for early-stage clinical research, expansion, key hires, and technological innovation.
Post-funding, Elena Viboch, a partner at General Catalyst, will join Medeloop’s board.
Medeloop leverages AI to accelerate disease research and drug development. The company’s AI-driven platform integrates and analyzes EMR/EHR, omics, genetics, and environmental data to facilitate research. It streamlines researcher discovery and simplifies grant applications, data collection, and manuscript submissions.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.